Federal Circuit affirms MINOCIN patent validity and infringement against Nexus
CorMedix's subsidiary Melinta won a patent litigation case where the Federal Circuit upheld findings that Nexus Pharmaceuticals infringed MINOCIN patents and affirmed a permanent injunction blocking generic competition. The decision protects CorMedix's market exclusivity for its
View filing at SEC.gov →